19 June 2013
Keywords: activase, gains, backing, stroke, indication, genentech, won
Article | 17 June 1996
Genentech has won a recommendation for approval to market Activase (alteplase) for a new indication, the treatment of acute ischemic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.